Shares of Humacyte, Inc. (NASDAQ:HUMAW – Get Free Report) traded up 7.9% during mid-day trading on Monday . The company traded as high as $1.52 and last traded at $1.50. 14,350 shares traded hands during mid-day trading, a decline of 50% from the average session volume of 28,826 shares. The stock had previously closed at $1.39.
Humacyte Stock Up 7.9 %
The company’s fifty day simple moving average is $1.76 and its 200 day simple moving average is $1.99.
About Humacyte
Humacyte, Inc engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection.
See Also
- Five stocks we like better than Humacyte
- Why is the Ex-Dividend Date Significant to Investors?
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- Dividend Payout Ratio Calculator
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- The How And Why of Investing in Oil Stocks
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Humacyte Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humacyte and related companies with MarketBeat.com's FREE daily email newsletter.
